Back to Journals » OncoTargets and Therapy » Volume 11

Case report of a primary prostatic urothelial carcinoma patient with sustained fever

Authors Zhang S, Guo Z

Received 13 January 2018

Accepted for publication 17 May 2018

Published 3 August 2018 Volume 2018:11 Pages 4547—4550

DOI https://doi.org/10.2147/OTT.S162441

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 3

Editor who approved publication: Dr XuYu Yang


Songsong Zhang, Zhenxing Guo

Department of Hematology/Oncology, Cancer Center, First Hospital of Tsinghua University, Beijing, 100016, People’s Republic of China

Abstract:
A 77-year-old-male patient presented with recurrent gross hematuria for 3 months with a fever for 1 month, and so was admitted to The First Hospital of Tsinghua University. The medical history revealed the patient exhibited no symptoms of night sweat, dysuria, or abdominal pain. The patient experienced sustained fever with maximal temperature of 39°C for 1 month without any infectious symptoms. The biochemical examination revealed that renal and hepatic function tests were normal. Serum prostate-specific antigen and free prostate-specific antigen were at a normal level. Enhanced computed tomography and magnetic resonance imaging was performed and indicated prostatic cancer with bilateral pulmonary metastases. Subsequently, prostatic urothelial carcinoma was confirmed by a histopathology assay of the prostate biopsy. Following 1 course of chemotherapy, the temperature of the patient returned to normal.

Keywords: prostatic urothelial carcinoma, primary, fever, chemotherapy, metastases

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]